Cincinnati.com: Study involving UC could help ID genetic markers for opioid addiction
UC expert leads research that is among the first to examine ways of preventing opioid use disorder
Caroline Freiermuth, MD, of the Department of Emergency Medicine at the UC College of Medicine, is featured in a story published on Cincinnati.com on research she is leading that hopes to identify potential genetic factors in opioid addition. The research, funded by the Ohio Attorney General's office, is among the first to examine the pharmacogenomics of opioid addiction.
Pharmacogenomics, a relatively new field, is the study of how genes affect a person's response to drugs.
A patient volunteering for the pharmacogenomics study is swabbed at the UC Department of Emergency Medicine. Photo credit/Jonathan Quilter/Ohio Attorney General's Office
"We don't know who will be harmed by opioids," Freiermuth said in a YouTube video outlining the research project. "We know … there's a genetic link to many substance use disorders." She and others from UC and Ohio State University's Wexner Medical Center hope to zero in on the genetic identifiers of opioid addiction.
The researchers are recruiting patients from emergency departments who have the chronic health disorder and patients who do not have the condition. Freiermuth, who started the work in May, said she's had a great response from patients at the UC Medical Center. UCMC has now reached the initial milestone of 100 patients enrolled.
Read the full story here and find out more about the research here.
Lead image/Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.